MedTrace Logo

Drug-eluting Balloon for Treatment of Non-atherosclerotic Renal Artery Stenosis

NCT04366596 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 90

Last updated 2020-04-29

No results posted yet for this study

Summary

Efficacy of drug eluting balloon(DEB) for non-atherosclerotic renal artery stenosis will be tested in this study. The intervention group will be treated with paclitaxel eluting balloon. The control group will be treated with plain old balloon(POB). The primary endpoint is efficacy of blood pressure control.

Conditions

  • Hypertension, Renovascular

Interventions

DEVICE

Angioplasty with paclitaxel eluting balloon

The patients will be treated with renal artery angioplasty using paclitaxel eluting balloon

DEVICE

Angioplasty with plain old balloon

Angioplasty with plain old balloon

Sponsors & Collaborators

  • Peking Union Medical College Hospital

    lead OTHER

Principal Investigators

  • Yuehong Zheng, MD · Peking Union Medical College Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-10-01
Primary Completion
2023-10-01
Completion
2023-10-01

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04366596 on ClinicalTrials.gov